2min chapter

VJHemOnc Podcast cover image

CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024

VJHemOnc Podcast

CHAPTER

Exploring Treatment Strategies for High-Risk Multiple Myeloma

This chapter explores the use of Soltacel for high-risk multiple myeloma patients, focusing on its approval after just one prior therapy. The discussion also covers the role of MRD in treatment decisions, comparisons between CAR-T and bispecific therapies, and the need for timely intervention in high-risk cases.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode